Inhibitors of bruton's tyrosine kinase
US9139591B2 · kind B2 · utility
35Cited by
35References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 6, 2012 |
| Grant date | Sep 22, 2015 |
| Priority date | — |
| Expiry date | Nov 30, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are irreversible kinase inhibitor compounds exemplified by the following structure Formula (A2):methods for synthesizing such irreversible inhibitors, and methods for using such irreversible inhibitors in the treatment of a B cell proliferative disorder or a mast cell proliferative disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.